Aziyo Biologics Inc
-0.13 (-7.98%)
Company Name Stock Ticker Symbol Market Type
Aziyo Biologics Inc AZYO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.13 -7.98% 1.50 20:00:00
Open Price Low Price High Price Close Price Prev Close
1.60 1.51 1.64 1.51 1.63
more quote information »

Recent News

Date Time Source Heading
3/31/20237:07IHNWFeaturedTiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference
3/23/202317:10EDGARAnnual Report (10-k)
3/22/202316:07EDGARCurrent Report Filing (8-k)
3/22/202316:01GLOBEAziyo Biologics Reports Record Full Year 2022 Revenues
3/22/202308:30GLOBEAziyo Biologics and Sientra Announce SimpliDerm® Partnership..
3/20/202317:27EDGARCurrent Report Filing (8-k)
3/20/202308:00GLOBEAziyo Biologics Provides Update on FDA Submission for..
3/15/202316:05GLOBEAziyo Biologics to Report Fourth Quarter and Full Year 2022..
2/27/202308:15GLOBEAziyo Biologics to Present at the Cowen 43rd Annual Health..
2/14/202317:14EDGARAmended Statement of Ownership (sc 13g/a)
2/13/202318:56EDGARInitial Statement of Beneficial Ownership (3)
2/13/202316:35EDGARAmended Statement of Ownership (sc 13g/a)
1/31/202308:00PRNUSSWK Holdings Provides Portfolio Update Highlighting Recent..
1/09/202308:24EDGARCurrent Report Filing (8-k)
1/09/202308:15GLOBEAziyo Biologics Announces Record Annual Net Sales in..
12/30/202216:07EDGARCurrent Report Filing (8-k)
12/28/202215:57EDGARStatement of Changes in Beneficial Ownership (4)
12/27/202218:10EDGARStatement of Changes in Beneficial Ownership (4)
12/16/202216:47EDGARStatement of Changes in Beneficial Ownership (4)
12/15/202216:32EDGARInitial Statement of Beneficial Ownership (3)
12/15/202208:08EDGARCurrent Report Filing (8-k)
12/15/202208:00GLOBEAziyo Biologics Announces Funding of Additional $4 Million..
12/15/202206:20EDGARAmended Statement of Ownership (sc 13g/a)
12/12/202217:09EDGARStatement of Changes in Beneficial Ownership (4)
12/07/202216:32EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
12/05/202206:32EDGARCurrent Report Filing (8-k)
12/02/202206:06EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
12/01/202209:04GLOBEAziyo Biologics, Inc. Announces Pricing of $11.2 Million..
11/30/202216:08GLOBEAziyo Biologics, Inc. Announces Proposed Public Offering of..
11/21/202216:05GLOBEAziyo Biologics to Participate in Upcoming Investor..
11/14/202217:36EDGARQuarterly Report (10-q)
11/14/202216:01GLOBEAziyo Biologics Reports Strong Third Quarter 2022 Revenue
11/07/202216:05GLOBEAziyo Biologics to Report Third Quarter 2022 Financial..
10/24/202217:04EDGARStatement of Changes in Beneficial Ownership (4)
10/24/202216:55EDGARStatement of Changes in Beneficial Ownership (4)
10/24/202209:15EDGARCurrent Report Filing (8-k)
10/24/202208:00GLOBEAziyo Biologics Appoints Seasoned Healthcare Executive,..
10/21/202214:40EDGARInitial Statement of Beneficial Ownership (3)
10/18/202216:05PRNUSSWK Holdings Provides Portfolio Update Highlighting Recent..
10/11/202216:35GLOBEAziyo Biologics Strengthens Leadership Team and Organizes..
9/12/202217:14EDGARStatement of Changes in Beneficial Ownership (4)
9/12/202217:10EDGARStatement of Changes in Beneficial Ownership (4)
9/12/202217:06EDGARStatement of Changes in Beneficial Ownership (4)
8/26/202209:00GLOBEAziyo Biologics Appoints Michelle LeRoux Williams, Ph.D as..
8/17/202216:05GLOBEAziyo Biologics to Present at the Inaugural Gilmartin Group..
8/15/202216:19EDGARCurrent Report Filing (8-k)
8/11/202216:05GLOBEAziyo Biologics Announces Second Quarter 2022 Financial..
8/10/202218:56GLOBEAziyo Biologics Announces $25 Million Loan Facility with SWK..
8/09/202217:57GLOBEAziyo Biologics Co-Founder and Regenerative Medicine..
7/28/202216:05GLOBEAziyo Biologics to Report Second Quarter 2022 Financial..
6/23/202216:07EDGARStatement of Changes in Beneficial Ownership (4)